J B CHEMICALS AND PHARMA

Members of the Exchange are hereby informed that the trading in equity shares of JB Chemicals & Pharmaceuticals Limited shall be suspended w.e.f. July 17, 2026 (i.e., closing hours of trading on July 16, 2026) on account of the Scheme of Amalgamation.

JBCHEPHARM:The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to announcement dated 05-Jul-2024, regarding " JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.".On basis of above the Company is required to clarify following:The response of the Company is awaited.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to recent news item captioned Lupin, Piramal Healthcare in Race for Stake in JB Chemicals. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. JB Chemicals & Pharmaceuticals Limited has submitted their response.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to news item captioned ��Lupin, Piramal Healthcare in Race for Stake in JB Chemicals��. The response from the Company is awaited.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to recent news item captioned "JB Chemicals promoters to offload 57% stake". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. JB Chemicals & Pharmaceuticals Limited has submitted their response.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to recent news item captioned "JB Chemicals promoters to offload 57% stake". The response from the company is awaited.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited with respect to recent news item captioned Company's Panoli tablet manufacturing facility gets inspected with zero 483 by US FDA -US FDA inspected Panoli tablet manufacturing facility last week. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. JB Chemicals & Pharmaceuticals Limited has submitted their response.

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited, with respect to recent news item captioned "Company's Panoli tablet manufacturing facility gets inspected with zero 483 by US FDA. US FDA inspected Panoli tablet manufacturing facility last week". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the afore

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that with reference to the news item appeared in 'The Business Standard' dated August 31, 2005, titled 'JB Chem to buy Russian Firm', the Company denies the said news report as baseless and incorrect. The Company has further stated that the said news item is only a rumour as the Company does not have any acquisition plans in Russia for now. Shri J B Mody, Chairman & Managing Director of the Company has already denied the said news report on CNBC (nationwide) on August 31, 2005 instantly. Further, the Company as a matter of policy ha

Clarification of News : The press had reports that JB Chemicals & Pharmaceuticals Limited is planning a bonus issue for its shareholders. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. JB Chemicals & Pharmaceuticals Ltd. has vide its letter inter-alia stated, "We deny the said news report as baseless and incorrect. The said news item is only a rumour, as the Company does not have any plans to announce bonus in th